One explanation for this is our inability to differentiate between symptoms attributable to detrusor overactivity (DO) and those caused by bladder ... treatment comprises men with urodynamic ...

Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size. Eur. Urol. 55 , 472–479 (2009).

in men with overactive bladder and benign prostatic hyperplasia. With regard to efficacy, 80% of patients receiving tolterodine ER plus tamsulosin had perceived a benefit from their treatment ...

Men with overactive bladder had significant 95% reduced odds of urinary tract cancers compared with a reference group of men with urolithiasis, after adjusting for age. Overactive bladder (OAB ...

Your health care providers can help you discover the treatments best for you. Overactive bladder can be triggered, or irritated, by many things, from medications to a simple cola. It's a great ...

This phenotypic approach could avoid unnecessary or ineffective treatment ... is a major risk factor for falls. Overactive Bladder in Men with Newly Diagnosed Localized Prostate Cancer Overactive ...

Mostly, older women are more prone to an overactive bladder usually, but a recent representative cohort study indicates the ...

An overactive bladder (OAB) causes a sudden and frequent urge to urinate, often leading to involuntary leakage. While conventional treatments such as medications, bladder training, and lifestyle ...

Somewhere between 15 and 20 million people are affected by overactive bladder and/or incontinence ... as women get a little bit older. But men are also affected by it too. where their prostate ...

In summary, PTNS is a noninvasive treatment for OAB and it has been shown to be useful in reducing overactive bladder symptoms when given weekly for 12 weeks. Improvement has been seen in ...

"We are thrilled to have the support of leading investors and partners who share our vision of transforming overactive bladder treatment," remarked Avner Geva, CEO of Vensica. "This funding will ...